SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-254489
Filing Date
2017-08-10
Accepted
2017-08-10 16:19:03
Documents
1
Group Members
VIFOR (INTERNATIONAL) LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d398820dsc13da.htm SC 13D/A 41358
  Complete submission text file 0001193125-17-254489.txt   42947
Mailing Address UNTERMATTWEG 8 BERNE V8 CH-3027
Business Address UNTERMATTWEG 8 BERNE V8 CH-3027 41 58 852 81 11
Vifor Pharma Ltd. (Filed by) CIK: 0001416422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Subject) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88058 | Film No.: 171021686
SIC: 2834 Pharmaceutical Preparations